We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.53B
AUM Growth
+$430M
Cap. Flow
+$424M
Cap. Flow %
11.99%
Top 10 Hldgs %
19.3%
Holding
632
New
232
Increased
83
Reduced
96
Closed
207

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$111M
2
EA icon
Electronic Arts
EA
+$45.7M
3
AKAM icon
Akamai
AKAM
+$45.1M
4
ALIT icon
Alight
ALIT
+$40.9M
5
MRK icon
Merck
MRK
+$39.9M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$62.7M
2
BBY icon
Best Buy
BBY
+$59.6M
3
TKO icon
TKO Group
TKO
+$54.5M
4
HAS icon
Hasbro
HAS
+$47.1M
5
NSC icon
Norfolk Southern
NSC
+$46.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.97%
2 Technology 13.31%
3 Industrials 12.3%
4 Healthcare 9.88%
5 Communication Services 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLP icon
326
Alerian MLP ETF
AMLP
$13B
$792K 0.02%
16,500
-17,547
-52% -$820K
ISRG icon
327
Intuitive Surgical
ISRG
$127B
$761K 0.02%
1,710
-3,156
-65% -$1.26M
CLDX icon
328
CALL
Celldex Therapeutics
CLDX
$2.99B
$751K 0.02%
+20,300
New +$766K
AAP icon
329
Advance Auto Parts
AAP
$3.35B
$743K 0.02%
+11,726
New +$840K
MNTK icon
330
Montauk Renewables
MNTK
$243M
$731K 0.02%
128,262
+105,762
+470% +$489K
SNY icon
331
Sanofi
SNY
$103B
$728K 0.02%
+15,000
New +$724K
GTN icon
332
Gray Television
GTN
$415M
$709K 0.02%
+136,345
New +$798K
NAMS icon
333
NewAmsterdam Pharma
NAMS
$3.25B
$706K 0.02%
36,776
-42,058
-53% -$844K
MSOS icon
334
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
$706K 0.02%
96,251
-367,639
-79% -$3.21M
HCP
335
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$704K 0.02%
+20,900
New +$650K
HNRG icon
336
CALL
Hallador Energy
HNRG
$670M
$699K 0.02%
+90,000
New +$564K
CHWY icon
337
Chewy
CHWY
$9.25B
$694K 0.02%
+25,479
New +$485K
LBPH
338
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$694K 0.02%
25,669
-89,811
-78% -$1.77M
XLU icon
339
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$693K 0.02%
20,354
-44,360
-69% -$1.52M
HUT
340
CALL
Hut 8
HUT
$12.1B
$675K 0.02%
+45,000
New +$433K
KURA icon
341
Kura Oncology
KURA
$800M
$674K 0.02%
+32,721
New +$673K
AXSM icon
342
Axsome Therapeutics
AXSM
$11.2B
$671K 0.02%
8,336
-560
-6% -$41.5K
RIVN icon
343
PUT
Rivian
RIVN
$22B
$663K 0.02%
49,400
-45,600
-48% -$476K
ZBRA icon
344
Zebra Technologies
ZBRA
$14B
$656K 0.02%
+2,123
New +$646K
LSXMK
345
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$651K 0.02%
+29,399
New +$699K
WOOF icon
346
Petco
WOOF
$797M
$644K 0.02%
+170,338
New +$435K
LGF.B
347
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$643K 0.02%
+75,000
New +$672K
MNRO icon
348
Monro
MNRO
$383M
$625K 0.02%
+26,175
New +$698K
DAWN
349
DELISTED
Day One Biopharmaceuticals
DAWN
$619K 0.02%
44,943
-16,384
-27% -$240K
IYT icon
350
iShares US Transportation ETF
IYT
$2.26B
$609K 0.02%
9,304
– –
12 13
14
15 16

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2024 Portfolio in Review

As of Q2 2024, J. Goldman & Co held 632 positions worth $3.53B, up 14% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

J. Goldman & Co deployed $424M of net new capital in Q2 2024, opening 232 new positions and adding to 83 existing holdings. Its largest new stake was Constellation Brands: 431,859 shares worth $111M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Texas Instruments, an estimated $30M trimmed.

  • J. Goldman & Co's largest Q2 2024 buy was Constellation Brands: 431,859 shares worth $111M.
  • J. Goldman & Co added most to Merck in Q2 2024, an estimated $39.9M increase.
  • J. Goldman & Co's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $30M.
  • J. Goldman & Co fully exited Sherwin-Williams in Q2 2024, selling an estimated $62.7M.
  • J. Goldman & Co's ten largest holdings make up 19% of its $3.53B portfolio in Q2 2024.
  • J. Goldman & Co opened 232 new positions and closed 207 in Q2 2024.
  • J. Goldman & Co's portfolio value rose 14% quarter-over-quarter to $3.53B.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.